Mechanisms of action and therapeutic prospects of regulatory T cells in fundus neovascular diseases
Author:
Corresponding Author:

Affiliation:

Clc Number:

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Neovascular diseases of the fundus are a group of disorders caused by pathological abnormal proliferation of blood vessels in the choroid and retina, which induces a series of clinical pathological changes and represents one of the major causes of fundus tissue damage and severe visual impairment. In recent years, immune-inflammatory responses have been confirmed as a key driver of neovascularization. As a T cell subset with negative immune regulatory functions and a core regulator for maintaining immune homeostasis, regulatory T cells(Tregs)play an increasingly prominent role in the initiation and progression of fundus neovascularization and have become a research hotspot in this field. This review systematically summarizes the core mechanisms by which Tregs mediate angiogenesis via modulation of the ocular immune microenvironment, illustrates their context-dependent dual effects under different disease conditions and at various disease stages, and outlines cutting-edge Treg-targeted therapeutic strategies. It aims to provide forward-looking references for mechanistic research and translational clinical diagnosis and treatment of such diseases.

    Reference
    Related
    Cited by
Get Citation

Xu Lihe, Liu Lian. Mechanisms of action and therapeutic prospects of regulatory T cells in fundus neovascular diseases. Guoji Yanke Zazhi( Int Eye Sci) 2026;26(12):2148-2153

Copy
Article Metrics
  • Abstract:
  • PDF:
Publication History
  • Received:July 15,2026
  • Revised:October 13,2026
  • Adopted:
  • Online: November 09,2026
  • Published: